« Back
Home /
Pavunalimab Biosimilar - Anti-LAG3;CTLA4 mAb - Research Grade

Pavunalimab Biosimilar - Anti-LAG3;CTLA4 mAb - Research Grade

€1,240.00

Excl. VAT

Item no.	PX-TA1699-1MG
Manufacturer	ProteoGenix
Amount	1mg
Category	Oncology Antibodies By Cell Type Carcinoma Primary Antibodies
Type	Antibody Primary
Specific against	other
Host	XtenCHO
ECLASS 10.1	32160702
ECLASS 11.0	32160702
UNSPSC	12352203
Alias	ANTI-CTLA-4/LAG-3 BISPECIFIC ANTIBODY XMAB22841, IMMUNOGLOBULIN HALF-IG G1-KAPPA/SCFV-H-CH2-CH3, ANTI-(HOMO SAPIENS LAG3 (LYMPHOCYTE ACTIVATING 3, LYMPHOCYTE-ACTIVATION 3, CD223)) AND ANTI-(HOMO SAPIENS CTLA4 (CYTOTOXIC T-LYMPHOCYTE-ASSOCIATED PROTEIN 4,
Available
Clonality	Monoclonal Antibody
Subtype	Bispecific , IgG1, Kappa
Expression system	XtenCHO
Buffer	PBS buffer PH7.5
Storage condition	store at -80C

Note: The presented information and documents (Manual, Product Datasheet, Safety Datasheet and Certificate of Analysis) correspond to our latest update and should serve for orientational purpose only. We do not guarantee the topicality. We would kindly ask you to make a request for specific requirements, if necessary.

All products are intended for research use only (RUO). Not for human, veterinary or therapeutic use.

Request Data Sheet

Request product datasheet

Request safety datasheet

Simple Order Order Subscription

Amount: 1mg

Listprice: €1,240.00

Price: €1,240.00

available

Delivery expected until 9/18/2025

Quantity:

Compare